The Claim

The HERV-K10 and IDDMK1,222 envelope proteins share 95% sequence identity, and antibodies targeting these proteins exhibit extensive cross-reactivity, indicating that immune responses recognize shared epitopes rather than unique viral variants.

Source: Autoantibodies to human endogenous retrovirus‐K are frequently detected in health and disease and react with multiple epitopes

What the research says

Supports is higher

Support is ahead, but a single strong opposing study can change this.

Supports
38score
Challenges
0score

These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.

How it works
1 study reviewed
In plain English

Two viral proteins, HERV-K10 and IDDMK1,222, have nearly identical sequences, and antibodies that bind to one also bind strongly to the other. This suggests the immune system is responding to common structural features, not distinct differences between them.

See the scientific wording

The HERV-K10 and IDDMK1,222 envelope proteins are 95% identical in sequence, and antibodies to these proteins cross-react extensively, indicating that immune responses to these elements are not directed against unique viral variants but shared epitopes.

What the research says

1 study

  1. Study: Autoantibodies to human endogenous retrovirus‐K are frequently detected in health and disease and react with multiple epitopes

    Scientists found that the immune system’s antibodies attack similar parts of two closely related viral proteins, meaning they can’t tell them apart — so the body isn’t reacting to unique viruses, but to shared features they both have.

Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies

Fit Body Science verdict — we translate health claims into clear verdicts backed by peer-reviewed research.

Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.